» Articles » PMID: 32244712

Erythropoiesis and Red Cell Indices Undergo Adjustments During Pregnancy in Response to Maternal Body Size but Not Inflammation

Overview
Journal Nutrients
Date 2020 Apr 5
PMID 32244712
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

During human pregnancy, iron requirements gradually increase, leading to higher amounts of erythropoietin (EPO) and reticulocytes, and changes in erythrocyte size and density. Women with pregestational obesity experience "obesity hypoferremia" during pregnancy, which alters iron homeostasis. In this study we aimed to describe the relationship between EPO and iron nutrition status during nonanemic pregnancy, and to explore whether obesity and inflammation influence erythropoiesis and red cell indices. We conducted a secondary analysis of a cohort followed throughout pregnancy. Participants were nonanemic women assigned to two study groups based on pregestational body mass index (pgBMI): adequate weight (AW, n = 53) or obesity (Ob, n = 40). All received a multivitamin supplement. At gestational ages (GA) 13, 21, 28 and 34, we measured hemoglobin and red cell indices with an ACT-5DIFF hematology counter, and reticulocyte percentage by manual cell counting. EPO, interleukin (IL-6) and markers of iron status, i.e., hepcidin, serum transferrin receptor (sTfr) and ferritin, were measured by ELISA. Bivariate correlations showed that EPO was positively associated with pgBMI, GA, sTfr and IL-6, but negatively associated with hepcidin, ferritin and hemoglobin, and unrelated to iron intake. Generalized linear models adjusted for confounding factors showed that EPO and erythrocyte concentrations were significantly higher in women in the Ob group, while mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and red cell distribution width (RDW) were lower; reticulocytes and mean corpuscular hemoglobin concentration (MCHC) were not different. Differences were not altered when controlling for inflammation (IL-6). These changes suggest that, in addition to altering iron metabolism, a larger maternal body size during pregnancy results in higher erythropoiesis without increasing hemoglobin, which is exhibited in the latter being distributed among more and smaller erythrocytes.

Citing Articles

Iron status and anemia in a representative sample of US pregnant women is not associated with pre-pregnancy BMI: Results from the NHANES (1999-2010) study.

Ciulei M, Gallagher K, Ba D, Beck C, Pobee R, Gernand A PLoS One. 2024; 19(9):e0300912.

PMID: 39255312 PMC: 11386453. DOI: 10.1371/journal.pone.0300912.


Hepcidin across pregnancy and its correlation with maternal markers of iron and inflammation, maternal body weight outcomes, and offspring neurodevelopmental outcomes: a systematic review and meta-analysis.

Ssewanyana D, Borque S, Lye S, Matthews S AJOG Glob Rep. 2023; 3(3):100222.

PMID: 37645642 PMC: 10461250. DOI: 10.1016/j.xagr.2023.100222.


Pregnancy-associated haemolytic anaemia: A cause not to be forgotten.

Creeper K, Graham D Obstet Med. 2023; 16(1):59-61.

PMID: 37139507 PMC: 10150307. DOI: 10.1177/1753495X211045337.


Mean corpuscular hemoglobin predicts the length of hospital stay independent of severity classification in patients with acute pancreatitis.

Lin H, Yu T, Xu R, Li X Open Med (Wars). 2022; 17(1):1449-1454.

PMID: 36128446 PMC: 9449682. DOI: 10.1515/med-2022-0559.


The combination of and promotes erythroid lineages and modulates follicle-stimulating hormone and luteinizing hormone levels in pregnant mice infected with .

Djati M, Christina Y, Rifai M Vet World. 2021; 14(5):1398-1404.

PMID: 34220146 PMC: 8243661. DOI: 10.14202/vetworld.2021.1398-1404.


References
1.
Conrad K, Benyo D, Miles T . Expression of erythropoietin by the human placenta. FASEB J. 1996; 10(7):760-8. DOI: 10.1096/fasebj.10.7.8635693. View

2.
Kowalska-Kanka A, Maciejewski T, Niemiec K . The role and regulation of secretion of erythropoietin in pregnancy. Med Wieku Rozwoj. 2013; 17(3):270-5. View

3.
Elsayed M, Sharif M, Stack A . Transferrin Saturation: A Body Iron Biomarker. Adv Clin Chem. 2016; 75:71-97. DOI: 10.1016/bs.acc.2016.03.002. View

4.
Fisher A, Nemeth E . Iron homeostasis during pregnancy. Am J Clin Nutr. 2017; 106(Suppl 6):1567S-1574S. PMC: 5701706. DOI: 10.3945/ajcn.117.155812. View

5.
Peyrin-Biroulet L, Williet N, Cacoub P . Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015; 102(6):1585-94. DOI: 10.3945/ajcn.114.103366. View